Business Of Biotech

Business Of Biotech

Author: Ben Comer Language: English Episodes: 100
Navigating the complex journey from a promising scientific idea to a commercially viable therapy involves far more than lab work. Business Of Biotech, hosted by Ben Comer, exists in that crucial space where scientific ambition meets real-world execution. This podcast speaks directly to the founders, executives, and visionaries steering emerging biopharma companies, offering a grounded conversation about the non-scientific hurdles that define success. You'll hear detailed discussions on the organizational, financial, and operational realities of the industry-from securing funding and building a team to managing clinical trials, manufacturing, and regulatory pathways. Each episode leans on the hard-earned wisdom of accomplished guests who share commentary and practical best practices. The focus is consistently on the multifaceted challenges leaders face while trying to bring a company from its earliest stages to impact in the clinic and the market. For anyone involved in building a life sciences company, this podcast provides an essential, candid look at the entire ecosystem, making the daunting path of biotech entrepreneurship feel a bit more navigable and a lot less lonely.
Episodes
Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos [not-audio_url] [/not-audio_url]

Duration: 46:39
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm…
Modernizing Clinical Trial Operations With Merck's Jennifer Sheller [not-audio_url] [/not-audio_url]

Duration: 55:39
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at Merck talks about simplifying trial protocol…
Engineering B Cells With Immusoft's Sean Ainsworth [not-audio_url] [/not-audio_url]

Duration: 53:51
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Sean Ainsworth, CEO and Chairman at Immusoft, talks about transitioning from the research bench to entrepreneurshi…
Biotech Collaboration Strategy With IGI's Cyril Konto, M.D. [not-audio_url] [/not-audio_url]

Duration: 58:41
We love to hear from our listeners. Send us a message. On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the promise of multi-specific antib…
Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D. [not-audio_url] [/not-audio_url]

Duration: 42:48
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that emerged from stealth in May wit…